» Articles » PMID: 35002275

1,3,4, Oxadiazole Compound A3 Provides Robust Protection Against PTZ-Induced Neuroinflammation and Oxidative Stress by Regulating -Pathway

Overview
Journal J Inflamm Res
Publisher Dove Medical Press
Date 2022 Jan 10
PMID 35002275
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Epilepsy is a common neurological disorder that is characterized by recurrent episodes of seizures. Various studies have demonstrated a direct association between oxidative stress and inflammation in several neurological disorders including epilepsy. This study aimed to investigate the neuroprotective effects of a synthetic 1,3,4, oxadiazole compound A3 against pentylenetetrazole (PTZ)-induced kindling and seizure model.

Methodology: PTZ was administered in a sub-convulsive dose of 40 mg/kg for 15 days, at 48-hour intervals to male Swiss-Albino mice until animals were fully kindled. Two different doses of A3 (10 mg/kg and 30 mg/kg) were administered to find out the effective dose of A3 and to further demonstrate the relative role of nuclear factor E2-related factor () in the PTZ-induced kindled model.

Results: Our results demonstrated a compromised antioxidant capacity associated with a low level of catalase (CAT), superoxide dismutase (SOD), glutathione (GST), and glutathione S-transferase (GSH) in the kindled group. However, the PTZ-induced group demonstrated an elevated level of lipid peroxidation (LPO) level parallel to pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α), mediators as cyclooxygenase (COX-2), and nuclear factor kappa B (NFκB). Furthermore, the A3 treatment reversed these changes and overexpressed the antioxidant gene and its downstream . To further investigate the involvement of , we employed an -inhibitor, ie, all-trans retinoic acid (ATRA), that further aggravated the PTZ toxicity. Moreover, vascular endothelial growth factor (VEGF) expression was evaluated to assess the extent of BBB disruption.

Conclusion: The findings of this study suggest that A3 could mediate neuroprotection possibly by activating dependent downregulation of inflammatory cascades.

Citing Articles

Rev-erbα agonist SR9009 protects against cerebral ischemic injury through mechanisms involving Nrf2 pathway.

Sheng M, Chen X, Yu Y, Wu Q, Kou J, Chen G Front Pharmacol. 2023; 14:1102567.

PMID: 37063298 PMC: 10102520. DOI: 10.3389/fphar.2023.1102567.


Proanthocyanidins alleviate pentylenetetrazole-induced epileptic seizures in mice via the antioxidant activity.

Alyami N, Abdi S, Alyami H, Almeer R Neurochem Res. 2022; 47(10):3012-3023.

PMID: 35838827 DOI: 10.1007/s11064-022-03647-4.


Carveol Promotes Nrf2 Contribution in Depressive Disorders through an Anti-inflammatory Mechanism.

Muhammad A, Hao L, Al Kury L, Ur Rehman N, Alvi A, Badshah H Oxid Med Cell Longev. 2022; 2022:4509204.

PMID: 35295720 PMC: 8920705. DOI: 10.1155/2022/4509204.

References
1.
Waldbaum S, Patel M . Mitochondrial dysfunction and oxidative stress: a contributing link to acquired epilepsy?. J Bioenerg Biomembr. 2010; 42(6):449-55. PMC: 3102435. DOI: 10.1007/s10863-010-9320-9. View

2.
Ali A, Shah F, Zeb A, Malik I, Alvi A, Alkury L . NF-κB Inhibitors Attenuate MCAO Induced Neurodegeneration and Oxidative Stress-A Reprofiling Approach. Front Mol Neurosci. 2020; 13:33. PMC: 7121334. DOI: 10.3389/fnmol.2020.00033. View

3.
Karikas G, Schulpis K, Bartzeliotou A, Regoutas S, Thanopoulou C, Papaevangelou V . Early effects of sodium valproate monotherapy on serum paraoxonase/arylesterase activities. Scand J Clin Lab Invest. 2008; 69(1):31-5. DOI: 10.1080/00365510802248051. View

4.
Ho Y, Lin Y, Wu C, Chao Y, Chang A, Chan J . Peripheral inflammation increases seizure susceptibility via the induction of neuroinflammation and oxidative stress in the hippocampus. J Biomed Sci. 2015; 22:46. PMC: 4477313. DOI: 10.1186/s12929-015-0157-8. View

5.
Iqbal S, Shah F, Naeem K, Nadeem H, Sarwar S, Ashraf Z . Succinamide Derivatives Ameliorate Neuroinflammation and Oxidative Stress in Scopolamine-Induced Neurodegeneration. Biomolecules. 2020; 10(3). PMC: 7175202. DOI: 10.3390/biom10030443. View